Tags: Chemical Compound, Chemical Substance.

Darexaban (YM150) is a direct inhibitor of factor Xa created by Astellas Pharma. It is an experimental drug that acts as an anticoagulant and antithrombotic to prevent venous thromboembolism after a major orthopaedic surgery stroke in patients with atrial fibrillation and possibly ischemic events in acute coronary syndrome. It is used in form of the maleate. The development of darexaban was discontinued in September 2011.

Darexaban.svg
IUPAC name
N-(3-Hydroxy-2-[4-(4-methyl-14-diazepan-1-yl)benzoyl]aminophenyl)-4-methoxybenzamide

Loading...

This page contains content from the copyrighted Wikipedia article "Darexaban"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.